Q BioMed Announces Strontium89 Initial Uptake and Momentum in US and EuropeSeveral International Market Authorisations Expected in Q4 Expanding Access to South and Central America and...
Q BioMed Announces Initiation of GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program COVID-19 clinical trial planned for Q1 2021 supported by Canadian...
Q BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain Palliation in EU and Rest of World Named Patient...
FORT LEE, NJ -- March 19, 2019 -- InvestorsHub NewsWire -- GD Entertainment And Technology (OTC: GDET) (“GDET” or the “Company”) today announced CEO Anil Idnani was...
Four Trending Stocks Leading Biotech Sector on Heels of Latest R&D and Innovative Drug Therapy Advancements Coral Springs, FL -- July 27, 2016 -- InvestorsHub...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 19320 | 1.0E-6 | CS |
4 | -0.000399 | -99.75 | 0.0004 | 0.0004 | 1.0E-6 | 30425 | 1.0E-6 | CS |
12 | 0 | 0 | 1.0E-6 | 0.01 | 1.0E-6 | 18026 | 0.00019714 | CS |
26 | -0.000199 | -99.5 | 0.0002 | 0.0405 | 1.0E-6 | 17845 | 0.00017999 | CS |
52 | -0.001499 | -99.9333333333 | 0.0015 | 0.0405 | 1.0E-6 | 72927 | 0.00046843 | CS |
156 | -0.757399 | -99.9998679694 | 0.7574 | 0.7588 | 1.0E-6 | 618287 | 0.03468631 | CS |
260 | -0.749999 | -99.9998666667 | 0.75 | 3.75 | 1.0E-6 | 390857 | 0.21939693 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.